Financial Year |
March 31 2023 |
Monetary Funds |
17,922,883,000.00 |
Held-for-trading Financial Assets |
2,312,113,000.00 |
Notes Receivable |
1,028,190,000.00 |
Accounts Receivable |
20,875,921,000.00 |
Advances to Suppliers |
7,259,600,000.00 |
Other Receivables |
3,507,041,000.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
19,188,766,000.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
72,440,000.00 |
Other Current Assets |
1,182,594,000.00 |
Total Current Assets |
78,700,792,000.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
55,598,000.00 |
Long-term Equity Investment |
11,628,593,000.00 |
Investment Properties |
1,513,860,000.00 |
Fixed Assetes |
38,663,060,000.00 |
Under-construction Projects |
4,787,492,000.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
4,326,182,000.00 |
R&D expenses |
43,637,000.00 |
Goodwill |
2,555,272,000.00 |
Long-Term Deferred and Prepaid Expenses |
1,010,212,000.00 |
Deferred Income Tax Assets |
1,091,291,000.00 |
Other Non-Current Assets |
284,309,000.00 |
Sub-Total of Non-Current Assets |
69,630,411,000.00 |
Total Assets |
148,331,203,000.00 |
Short-Term Loans |
5,537,202,000.00 |
Trading Financial liabilities |
37,171,000.00 |
Notes Payable |
3,949,793,000.00 |
Accounts Payable |
15,575,901,000.00 |
Accounts Received In Advance |
7,776,000.00 |
Employee Compensation Payable |
4,687,888,000.00 |
Taxes Payable |
4,708,853,000.00 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
6,766,288,000.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
3,314,535,000.00 |
Other Current Liabilities |
911,031,000.00 |
Sub-Total of Current Liabilities |
61,198,799,000.00 |
Long-term Loans |
18,246,652,000.00 |
Bonds Payable |
1,883,565,000.00 |
Long-Term Accounts Payable |
90,860,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
1,264,840,000.00 |
Deferred Income Tax Liabilities |
287,909,000.00 |
Other Non-Current Liabilities |
25,520,000.00 |
Sub-Total of Non-Current Liabilities |
23,661,331,000.00 |
Total Liabilities |
84,860,130,000.00 |
Paid-In Capital(Or Share Stock) |
5,392,521,000.00 |
Capital Surplus |
4,234,013,000.00 |
Surplus Reserve |
4,300,255,000.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
31,741,668,000.00 |
Minority Stockholder's Interest |
14,654,913,000.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
48,816,160,000.00 |
Owner's Equity(Stockholder's Equity) |
63,471,073,000.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
148,331,203,000.00 |